Literature DB >> 27014357

Spontaneous Bleeding from Internal Pudendal Artery associated with Abciximab after Primary Percutaneous Coronary Intervention: Successful Treatment with Percutaneous Gel-Foam Embolization.

Seung-Eun Lee1, Hee-Bum Jo1, Hyoung-Ho Moon1, Dong-Jun Oh1, Ki-Hwan Kwon1, Jae-Hyun Kwon2, Young-Kwon Kim3, Yong-Seok Kim3.   

Abstract

We describe a case of spontaneous bleeding from a branch of the right internal pudendal artery that resulted in massive scrotal swelling in a patient who had underwent primary percutaneous coronary intervention with the use of abciximab concurrent with conventional anticoagulation and dual antiplatelet therapies for the treatment of acute ST-segment elevation myocardial infarction. This unusual complication was promptly identified by percutaneous peripheral arteriography and successfully treated with gel-foam embolization.

Entities:  

Keywords:  Abciximab; Bleeding; Percutaneous coronary intervention

Year:  2016        PMID: 27014357      PMCID: PMC4805571          DOI: 10.4070/kcj.2016.46.2.256

Source DB:  PubMed          Journal:  Korean Circ J        ISSN: 1738-5520            Impact factor:   3.243


  9 in total

1.  Management of a spontaneous renal capsule hematoma following cardiac catheterization involving use of a platelet glycoprotein IIb/IIIa inhibitor: a case report.

Authors:  Jean-François Dorval; Gilles Soulez; Colin Berry; Raoul Bonan
Journal:  Catheter Cardiovasc Interv       Date:  2007-06-01       Impact factor: 2.692

2.  Abciximab and alveolar hemorrhage.

Authors:  H Khanlou; G Eiger; S Yazdanfar
Journal:  N Engl J Med       Date:  1998-12-17       Impact factor: 91.245

3.  Late spontaneous epigastric arterial bleeding associated with abciximab: successful percutaneous treatment with coil gel-foam embolization.

Authors:  Madhavagopal Cherukuri; Ashish Pershad
Journal:  J Invasive Cardiol       Date:  2002-11       Impact factor: 2.022

4.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Patrick T O'Gara; Frederick G Kushner; Deborah D Ascheim; Donald E Casey; Mina K Chung; James A de Lemos; Steven M Ettinger; James C Fang; Francis M Fesmire; Barry A Franklin; Christopher B Granger; Harlan M Krumholz; Jane A Linderbaum; David A Morrow; L Kristin Newby; Joseph P Ornato; Narith Ou; Martha J Radford; Jacqueline E Tamis-Holland; Carl L Tommaso; Cynthia M Tracy; Y Joseph Woo; David X Zhao
Journal:  J Am Coll Cardiol       Date:  2012-12-17       Impact factor: 24.094

5.  Hemorrhagic and vascular complications after percutaneous coronary intervention with adjunctive abciximab.

Authors:  A V Cote; P B Berger; D R Holmes; C G Scott; M R Bell
Journal:  Mayo Clin Proc       Date:  2001-09       Impact factor: 7.616

6.  Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.

Authors:  Giuseppe De Luca; Harry Suryapranata; Gregg W Stone; David Antoniucci; James E Tcheng; Franz-Josef Neumann; Frans Van de Werf; Elliott M Antman; Eric J Topol
Journal:  JAMA       Date:  2005-04-13       Impact factor: 56.272

7.  Safety and efficacy of adjuvant glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention performed from the radial approach for acute ST segment elevation myocardial infarction.

Authors:  Zafar Iqbal; Marc Cohen; Charles Pollack; Patrick Goldstein; Uwe Zeymer; Kurt Huber; Olivier Barthelemy; Guillaume Cayla; Mounir Aout; Eric Vicaut; Gilles Montalescot
Journal:  Am J Cardiol       Date:  2013-03-22       Impact factor: 2.778

8.  Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapy.

Authors:  Guido Parodi; Giuseppe De Luca; Guia Moschi; Benedetta Bellandi; Renato Valenti; Angela Migliorini; Nazario Carrabba; David Antoniucci
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

Review 9.  Abciximab in the management of acute myocardial infarction with ST-segment elevation: evidence-based treatment, current clinical use, and future perspectives.

Authors:  Artur Dziewierz; Tomasz Rakowski; Dariusz Dudek
Journal:  Ther Clin Risk Manag       Date:  2014-07-18       Impact factor: 2.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.